Previous close | 3.1000 |
Open | 3.1000 |
Bid | 1.0000 |
Ask | 5.5000 |
Strike | 7.50 |
Expiry date | 2024-07-19 |
Day's range | 3.1000 - 3.1000 |
Contract range | N/A |
Volume | |
Open interest | 4 |
ORLANDO, Fla., May 02, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s first quarter 2024 financial results will be released before market open on Thursday, May 9, 2024. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, May 9, 2024 to discuss the financial results and recent corporate highlights.
ORLANDO, Fla., May 01, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR’s board of directors granted two newly-hired non-executive employees stock options to purchase an aggregate of 875 shares of the Company’s common stock. The options were granted as of May 1, 2024, as inducements material to each employee entering into employment with the Company. The options were granted in accordance with Nasdaq Listing Rule 5
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...